REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Efarpharma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Efarpharma S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Efarpharma S.A. is based in Ecuador. The head office is in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on February 16, 2016. There are currently 6 (2021) people employed by Efarpharma S.A.. From the latest financial highlights, Efarpharma S.A. reported a net sales revenue increase of 340% in 2021. Its’ total assets recorded a growth of 173.27%. The net profit margin of Efarpharma S.A. increased by 4.83% in 2021.

Headquarters
Pasaje Emilia Navas S3-120, Edificio Sin Nombre Bldg.
Quito; Pichincha;

Contact Details: Purchase the Efarpharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Efarpharma S.A. report to view the information.
Outstanding Shares:
Purchase the Efarpharma S.A. report to view the information.
Registered Capital:
Purchase the Efarpharma S.A. report to view the information.
Incorporation Date:
February 16, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Efarpharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
340%▲
Total operating revenue
341.5%▲
Operating profit (EBIT)
487.43%▲
Net Profit (Loss) for the Period
547.06%▲
Total assets
173.27%▲
Total equity
366.47%▲
Operating Profit Margin (ROS)
4.67%▲
Net Profit Margin
4.83%▲
Return on Equity (ROE)
19.97%▲
Quick Ratio
0.94%▲
Cash Ratio
0.91%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo